ALBERTDAVDNSEAlbert David LimitedHighNeutral
Announced Tue, 12 May · 20:02 IST

Albert David Limited has informed the Exchange about General Updates about KMP'S authorised to determine Materiality under Regulation 30(5) of SEBI(LODR),2015

Ceo Appointed ExternalManagement Changes View source PDF

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹730.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-2.3-2.1-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Limited's Board meeting on May 12, 2026 approved appointment of Mr. Amit Mahla as CEO (effective same day), filling a vacancy since Mr. Umesh Manohar Kunte resigned as Managing Director & CEO on December 18, 2025. FY2026 financials show significant decline: revenue Rs. 33,359.81 lakh vs Rs. 34,576.80 lakh prior year, with the company reporting a loss of Rs. 149.47 lakh (vs profit of Rs. 1,720.08 lakh in FY2025), and EPS of -Rs. 2.62 (vs Rs. 30.14). The Board recommended a 50% final dividend of Rs. 5 per share (face value Rs. 10), subject to shareholder approval at the August 6, 2026 AGM. Statutory auditors L.B. Jha & Co. issued an unmodified opinion. PricewaterhouseCoopers was reappointed as internal auditors and S. Gupta & Co. as cost auditors for FY2026-27. The company also updated authorized KMP contacts for SEBI disclosure purposes.

Likely market impact

The appointment of a new external CEO with pharma industry experience may provide strategic direction amid challenging financials. However, the significant drop in FY2026 profitability (from ~Rs. 17 crore profit to loss) is concerning for shareholders. The dividend offer provides some return despite the loss-making year.